Lung Cancer Clinical Trial

Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer

Summary

The investigators will evaluate the feasibility of implementing a low-intensity, patient-centered activity regimen (PCAR) that prioritizes education and communication over a 12-week period in advanced stage lung cancer patients. The primary outcomes will include number of patients increasing their overall step count over the study period and adherence to step count recommendations. Secondary outcomes will include quality of life (QoL), dyspnea, and depression scores before and after the intervention as well as a patient feedback questionnaire (to guide further interventions). The goals are to increase overall step count and obtain adherence of >50% of participants. The investigators will also assess whether the physical activity regimen influences markers of inflammation and glucose control and novel markers of cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pathologic evidence of advanced non-small cell stage lung cancer (NSCLC)
Approval of the treating clinician
Adult patients (age >21 years) willing to wear a FitBit® device (FitBit, Inc., San Francisco, CA)
Access to a smartphone, agree to receive twice/daily text messages for 12 weeks (including any costs), and willingness to download the FitBit application to their smartphone.
Low activity level as judged by a brief physical activity questionnaire (i.e., <150 minutes/week of moderate-intensity exercise, <75 minutes/week of vigorous aerobic exercise, or an equivalent combination).

Exclusion Criteria:

Memory impairment (as judged by the treating clinician)
Communication impairment (as judged by the treating clinician)
Treating clinician's request not to alter physical activity
Physical inability to safely walk (as judged by the treating clinician)

Study is for people with:

Lung Cancer

Estimated Enrollment:

40

Study ID:

NCT03352245

Recruitment Status:

Completed

Sponsor:

Yale University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Yale University
New Haven Connecticut, 06510, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

40

Study ID:

NCT03352245

Recruitment Status:

Completed

Sponsor:


Yale University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider